BioPorto A/S is trading at 0.29 as of the 28th of January 2026. This is a No Change since the beginning of the trading day. The stock's lowest day price was 0.29. BioPorto A/S has about a 29 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 30th of October 2025 and ending today, the 28th of January 2026. Click here to learn more.
BioPorto AS, an in-vitro diagnostics company, provides diagnostic tests and antibodies to clinicians and researchers worldwide. The company was founded in 2000 and is headquartered in Hellerup, Denmark. Bioporto operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. The company has 334.68 M outstanding shares. More on BioPorto AS
BioPorto AS [THOXF] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Small-Cap' category with a current market capitalization of 121.23 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BioPorto A/S's market, we take the total number of its shares issued and multiply it by BioPorto A/S's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. BioPorto A/S classifies itself under Healthcare sector and is part of Diagnostics & Research industry. The entity has 334.68 M outstanding shares.
BioPorto AS has accumulated about 86.72 M in cash with (64.58 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.32, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check BioPorto A/S Probability Of BankruptcyOwnership AllocationBioPorto A/S holds a total of 334.68 Million outstanding shares. BioPorto AS shows 19.84 percent of its outstanding shares held by insiders and 8.6 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check BioPorto Ownership Details
About 20.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.03. BioPorto A/S had not issued any dividends in recent years. BioPorto AS, an in-vitro diagnostics company, provides diagnostic tests and antibodies to clinicians and researchers worldwide. The company was founded in 2000 and is headquartered in Hellerup, Denmark. Bioporto operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 29 people.The quote for BioPorto AS is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about BioPorto AS contact the company at 45 45 29 00 00 or learn more at https://bioporto.com.
BioPorto A/S Investment Alerts
BioPorto A/S generated a negative expected return over the last 90 days
BioPorto A/S has some characteristics of a very speculative penny stock
The company reported the revenue of 24.25 M. Net Loss for the year was (57.11 M) with profit before overhead, payroll, taxes, and interest of 15.04 M.
BioPorto AS has accumulated about 86.72 M in cash with (64.58 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.32, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 20.0% of the company outstanding shares are owned by corporate insiders
BioPorto Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 121.23 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BioPorto A/S's market, we take the total number of its shares issued and multiply it by BioPorto A/S's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
BioPorto Profitablity
The company has Profit Margin (PM) of (2.5) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (2.82) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $2.82.
Technical Drivers
In respect to fundamental indicators, the technical analysis model gives you tools to check existing technical drivers of BioPorto A/S, as well as the relationship between them.
The output start index for this execution was zero with a total number of output elements of sixty-one. BioPorto A/S Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe BioPorto A/S price patterns.
Be your own money manager
Our tools can tell you how much better you can do entering a position in BioPorto A/S without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Portfolio Anywhere Now
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Other Information on Investing in BioPorto Pink Sheet
BioPorto A/S financial ratios help investors to determine whether BioPorto Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioPorto with respect to the benefits of owning BioPorto A/S security.